Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Alopecia, especially androgenic, may increase cardiovascular risk, but more research is needed.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

The revised Chinese Symptom Checklist-90 is more reliable and valid for psychological assessments.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

AI can accurately measure hair loss severity in alopecia areata.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

An automated method accurately assesses melanoma risk using 3D body images to analyze skin traits.

Genomic prediction can improve breeding strategies for Korean Sapsaree dogs.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Young Indians with coronary artery disease often have risk factors like smoking and central obesity, and cutaneous markers should be monitored for lifestyle changes.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

A scale was made to measure hair loss severity in African American women.

Scalp laxity, elasticity, and glidability are important in hair transplants and can predict scar width at the donor site.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Recognizing CVG can help diagnose systemic amyloidosis early.

Certain biomarkers can help distinguish between irritant and allergic contact dermatitis.

Researchers should follow the FACE-Q User's Guide for accurate results.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Trichoscopy effectively diagnoses allergic scalp contact dermatitis.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.